Ennis & Ennis, P.A.

Ennis & Ennis, PA Summarizes the Latest Fosamax Study that Confirms Long-Term Use of Biphosphonates, such as Fosamax and Boniva, Can Cause Weaker Bones

Ennis & Ennis, P.A. Explains the Recent Yaz/Yasmin Birth Control Settlement

Ennis & Ennis, P.A. Explains How Johnson & Johnson Sold Vaginal Mesh Devices Without FDA Approval

FDA Convening to Discuss Metal Hip Risks Explains Ennis & Ennis, P.A.

After FDA Denied Approval of the DePuy ASR Hip Resurfacing System, Johnson & Johnson Decided to Sell Off the Remaining Inventory Explains Ennis & Ennis, P.A.

Ennis & Ennis, P.A. Continues to Offer Free, Confidential Consultations to Patients Who Have Suffered Side Effects from Yaz/Yasmin As Some Claims Settle

Ennis & Ennis, P.A. Explains a Recent Study’s Findings on High Failure Rate of All-Metal Hip Implants

Ennis & Ennis, P.A. Provides an Update on the Actos Litigation

Ennis & Ennis, P.A. Explains the New FDA Warning on Multaq, a Heart Drug

Ennis & Ennis, P.A. Raises Questions about Yaz and Yasmin Ahead of the FDA Meeting